DE LA AGUILERA LUIS 4
4 · USCB FINANCIAL HOLDINGS, INC. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
USCB CEO Luis De La Aguilera Exercises Options, Sells Shares
What Happened
- Luis De La Aguilera, President, CEO and Director of USCB Financial Holdings (USCB), exercised stock options to acquire a total of 3,290 shares (805 on 2026-05-15 and 2,485 on 2026-05-18) at an exercise price of $12.05 per share (total exercise cost ~$39,644). He then sold the same 3,290 shares in open-market transactions (805 shares on 5/15 and 2,485 shares on 5/18) for combined proceeds of about $59,409. The transactions produced gross proceeds of ~$59.4K and, after exercise costs of ~$39.6K, a net cash difference of roughly $19.8K. The Form 4 shows corresponding derivative dispositions at $0 consistent with conversion/surrender of the exercised option interests.
Key Details
- Transaction dates and prices:
- 2026-05-15: exercised 805 shares @ $12.05 (acquired; $9,700) and sold 805 shares @ weighted $18.05 (proceeds $14,530; sales price range $18.02–$18.19 per F2).
- 2026-05-18: exercised 2,485 shares @ $12.05 (acquired; $29,944) and sold 2,485 shares @ weighted $18.06 (proceeds $44,879; sales price range $18.00–$18.17 per F3).
- Net cash effect (approx): sale proceeds ~$59,409 − exercise cost ~$39,644 = ~$19,765.
- Shares owned after transaction: not specified in the excerpted items. The filing’s footnotes list restricted stock holdings totaling 90,445 shares subject to vesting schedules (see F1).
- Vesting/option background: the related stock options vested one‑third per year beginning Sept. 27, 2022 (F4).
- Filing timeliness: Form 4 was filed on 2026-05-19 for transactions on 5/15 and 5/18; the filing is timely under the two‑business‑day rule.
Context
- This was an exercise of options followed by immediate open‑market sales (a cashless/close‑out pattern): the insider converted options into shares and sold them the same days. Such transactions commonly reflect liquidity or compensation realization rather than a directional endorsement or rejection of the company’s outlook. The filing’s weighted sale prices and price ranges (F2, F3) indicate the sales occurred in multiple trades.
Insider Transaction Report
Form 4
DE LA AGUILERA LUIS
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Class A Voting Common Stock
[F1]2026-05-15$12.05/sh+805$9,700→ 243,750 total - Sale
Class A Voting Common Stock
[F2][F1]2026-05-15$18.05/sh−805$14,530→ 242,945 total - Exercise/Conversion
Class A Voting Common Stock
[F1]2026-05-18$12.05/sh+2,485$29,944→ 245,430 total - Sale
Class A Voting Common Stock
[F3][F1]2026-05-18$18.06/sh−2,485$44,879→ 242,945 total - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-05-15−805→ 111,086 totalExercise: $12.05From: 2022-09-27Exp: 2031-09-27→ Common Stock (805 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-05-18−2,485→ 108,601 totalExercise: $12.05From: 2022-09-27Exp: 2031-09-27→ Common Stock (2,485 underlying)
Footnotes (4)
- [F1]Includes the grant of 27,632 shares of restricted stock which vest at a rate of one-third per year commencing on January 27, 2027, 17,102 shares of restricted stock from a grant of 25,653 shares which commenced vesting at a rate of one-third per year on January 21, 2026, 4,045 shares of restricted stock from a grant of 12,136 shares which commenced vesting at a rate of one-third per year on January 22, 2025, and 41,666 shares of restricted stock from a grant of 125,000 shares which commenced vesting at a rate of one-third per year on December 31, 2024.
- [F2]The price reported in column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $18.02 to $18.19, inclusive. The reporting person undertakes to provide to USCB, or any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.17, inclusive. The reporting person undertakes to provide to USCB, or any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The stock options vested at the rate of one-third per year commencing on September 27, 2022.
Signature
/s/ Robert Anderson by P.O.A. for Luis de la Aguilera|2026-05-19